Skip to content
Subscriber Only

Trump Springs Globalist Surprise With Medicare Drug-Pricing Plan

  • ‘Why shouldn’t they be allowed to negotiate?’ asks professor
  • U.S. would try out drug price program based on foreign costs
drugs hp
Photographer: Chris Ratcliffe/Bloomberg

The Trump administration’s drug-pricing plan puts the U.S. on a path toward policies like those in Europe, where governments use tight cost controls.

Under the new proposal unveiled at an event at the Department of Health and Human Services on Thursday, President Donald Trump and health secretary Alex Azar said that the administration would create a reference price for high-cost medicines paid for by Medicare, based on comparable prices from other countries.